{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:58:58Z","timestamp":1789473538941,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly multimorbid population and to determine the factors that influence their prescription, including the impact of age, comorbidities and frailty, evaluated through a comprehensive geriatric assessment. This cross-sectional study included all patients admitted to the acute geriatric department of a university hospital from November 2016 to January 2017. We included 304 consecutive hospitalized patients aged 88.7 \u00b1 5.5 years. One third of the population was treated with PAI. A total of 133 (43.8%) patients had a history of cardiovascular disease, 77 of whom were on PAI. For 16 patients, no indication was identified. The prescription or the absence of PAI were consistent with medical history in 61.8% of patients. In the multivariate analysis, among the 187 patients with an indication for PAI, neither age (odds ratio (OR) = 1.00; 95% confidence interval (CI): [0.91\u20131.08], per year of age), nor comorbidities (OR = 0.97; 95% CI: [0.75\u20131.26], per point of Charlson comorbidity index), nor cognitive disorders (OR = 0.98; 95% CI [0.91\u20131.06] per point of Mini Mental State Examination), nor malnutrition (OR = 1.07; 95% CI [0.96\u20131.18], per g\/L of albumin) were significantly associated with the therapeutic decision. PAI were less prescribed in primary prevention situations, in patients taking anticoagulants and in patients with a history of bleeding. In conclusion, a third of our older comorbid population of inpatients was taking PAI. PAI prescription was consistent with medical history for 61.8% of patients. Age, multimorbidity and frailty do not appear to have a significant influence on therapeutic decision-making. Further research is needed to confirm such a persistence of cardiovascular preventive strategies in frail older patients from other settings and to assess whether these strategies are associated with a clinical benefit in this specific population.<\/jats:p>","DOI":"10.3390\/ijerph17124541","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T08:54:50Z","timestamp":1592988890000},"page":"4541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population"],"prefix":"10.3390","volume":"17","author":[{"given":"Caroline","family":"Laborde","sequence":"first","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Barben","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Maria","family":"Mihai","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Nuss","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Vovelle","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"d\u2019Athis","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Medical Information, Fran\u00e7ois Mitterrand Hospital, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Jouanny","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-554X","authenticated-orcid":false,"given":"Alain","family":"Putot","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5518-9803","authenticated-orcid":false,"given":"Patrick","family":"Manckoundia","sequence":"additional","affiliation":[{"name":"Department of Geriatrics and Internal Medicine, Hospital of Champmaillot, University Hospital, 21000 Dijon, France"},{"name":"UMR Inserm\/U1093 Cognition, Action, Sensorimotor Plasticity, University of Burgundy and Franche Comt\u00e9, 21000 Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: Epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","article-title":"Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)","volume":"366","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000262306","article-title":"Stroke in the very old: Incidence, risk factors, clinical features, outcomes and access to resources\u2014A 22-year population-based study","volume":"29","author":"Rouaud","year":"2010","journal-title":"Cerebrovasc. Dis. Basel Switz."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1345\/aph.1D026","article-title":"Secondary prevention of coronary heart disease in the elderly","volume":"37","author":"Roth","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of Aspirin Use for Primary Prevention with Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"key":"ref_7","unstructured":"(2019, February 21). Haute Autorit\u00e9 de Sant\u00e9-Prescription M\u00e9dicamenteuse chez le Sujet Ag\u00e9 (PMSA)-Programme Pilote 2006\u20132013. Available online: https:\/\/www.has-sante.fr\/portail\/jcms\/c_675707\/fr\/prescription-medicamenteuse-chez-le-sujet-age-pmsa-programme-pilote-2006-2013."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1532-5415.2012.04071.x","article-title":"Underuse in elderly adults: An underestimated suboptimal prescribing","volume":"60","author":"Andro","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 324, 71\u201386.","DOI":"10.1136\/bmj.324.7329.71"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.STR.0000121648.74433.b5","article-title":"Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: The GIFA study","volume":"35","author":"Volpato","year":"2004","journal-title":"Stroke"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11739-016-1391-0","article-title":"Combination evidence-based therapy is effective in the oldest \u201cold patients\u201d following myocardial infarction. The \u2018Salute e Benessere nell\u2019Anziano\u2019 (SeBA) observational study","volume":"11","author":"Veronesi","year":"2016","journal-title":"Intern. Emerg. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/CIRCOUTCOMES.109.850883","article-title":"Use of antithrombotic medications among elderly ischemic stroke patients","volume":"4","author":"Lichtman","year":"2011","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11534650-000000000-00000","article-title":"Variability in the prescription of cardiovascular medications in older patients: Correlates and potential explanations","volume":"26","author":"Maraldi","year":"2009","journal-title":"Drugs Aging"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/jnnp.74.8.1100","article-title":"Antithrombotic drugs in secondary stroke prevention among a community dwelling older population","volume":"74","author":"Landi","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ageing\/27.4.493","article-title":"Medication use patterns among demented, cognitively impaired and cognitively intact community-dwelling elderly people","volume":"27","author":"Schmader","year":"1998","journal-title":"Age Ageing"},{"key":"ref_16","first-page":"407","article-title":"Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia","volume":"14","author":"Liu","year":"2017","journal-title":"J. Geriatr. Cardiol. JGC"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40266-019-00656-x","article-title":"Change in Prescribing for Secondary Prevention of Stroke and Coronary Heart Disease in Finnish Nursing Homes and Assisted Living Facilities","volume":"36","author":"Jokanovic","year":"2019","journal-title":"Drugs Aging"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pedersen, R.A., Petursson, H., and Hetlevik, I. (2019). Stroke follow-up in primary care: A Norwegian modelling study on the implications of multimorbidity for guideline adherence. BMC Fam. Pract., 20.","DOI":"10.1186\/s12875-019-1021-9"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2147\/CIA.S2468","article-title":"Polypharmacy: Misleading, but manageable","volume":"3","author":"Bushardt","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"ref_20","unstructured":"(2017, April 01). HAS Recommandations Agents Antiplaquettaires. Available online: http:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2012-07\/12irp06_reco_agents_antiplaquettaires.pdf."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/gerona\/gly110","article-title":"Frailty and Multimorbidity: A Systematic Review and Meta-analysis","volume":"74","author":"Vetrano","year":"2019","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/ageing\/afx166","article-title":"What is Comprehensive Geriatric Assessment (CGA)? An umbrella review","volume":"47","author":"Parker","year":"2018","journal-title":"Age Ageing"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.archger.2004.08.004","article-title":"Mini motor test: A clinical test for rehabilitation of patients showing psychomotor disadaptation syndrome (PDS)","volume":"40","author":"Mourey","year":"2005","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0148607112440285","article-title":"Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Characteristics recommended for the identification and documentation of adult malnutrition (undernutrition)","volume":"36","author":"White","year":"2012","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Manckoundia, P., Buzens, J.-B., Mahmoudi, R., d\u2019Athis, P., Martin, I., Laborde, C., Menu, D., and Putot, A. (2017). The prescription of antiplatelet medication in a very elderly population: An observational study in 15,141 ambulatory subjects. Int. J. Clin. Pract., 71.","DOI":"10.1111\/ijcp.13020"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10557-013-6455-z","article-title":"Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting","volume":"27","author":"Maggioni","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/2047487313494580","article-title":"Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: The EURHOBOP study","volume":"21","author":"Pereira","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1503\/cmaj.080295","article-title":"Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction","volume":"179","author":"Austin","year":"2008","journal-title":"CMAJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00228-014-1793-8","article-title":"Does age modify the relationship between adherence to secondary prevention medications and mortality after acute myocardial infarction? A nested case-control study","volume":"71","author":"Lenzi","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_31","first-page":"533","article-title":"The use of antiplatelet medication in hospitalised elderly patients","volume":"116","author":"Wawruch","year":"2015","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1472-8206.2010.00915.x","article-title":"Antiplatelet drugs in the elderly: Prescriptions often inappropriate and reduced tolerance by associated diseases and drugs","volume":"26","author":"Cadiou","year":"2012","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1532-5415.2006.00659.x","article-title":"Underuse of medications for chronic diseases in the oldest of community-dwelling older frail Japanese","volume":"54","author":"Kuzuya","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.STR.0000062888.90293.AA","article-title":"Secondary prevention of stroke in Italy: A cross-sectional survey in family practice","volume":"34","author":"Filippi","year":"2003","journal-title":"Stroke"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Aboal, J., Lla\u00f3, I., Garc\u00eda Garc\u00eda, C., Sans-Rosell\u00f3, J., Sambola, A., Andrea, R., Tom\u00e1s, C., Bonet, G., Ariza-Sol\u00e9, A., and Vi\u00f1as, D. (2019). Comorbidity and low use of new antiplatelets in acute coronary syndrome. Aging Clin. Exp. Res.","DOI":"10.1007\/s40520-019-01348-7"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.amjopharm.2009.11.002","article-title":"Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: Results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study","volume":"7","author":"Wright","year":"2009","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Calder\u00f3n-Larra\u00f1aga, A., Gimeno-Feliu, L.A., Gonz\u00e1lez-Rubio, F., Poblador-Plou, B., Lairla-San Jos\u00e9, M., Abad-D\u00edez, J.M., Poncel-Falc\u00f3, A., and Prados-Torres, A. (2013). Polypharmacy patterns: Unravelling systematic associations between prescribed medications. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0084967"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.therap.2017.06.003","article-title":"\u00c9valuation de la prescription des inhibiteurs de la pompe \u00e0 protons chez la personne \u00e2g\u00e9e de 75 ans et plus dans un service de g\u00e9riatrie aigu\u00eb","volume":"72","author":"Dipanda","year":"2017","journal-title":"Therapies"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Dalleur, O., Wouters, D., Spinewine, A., Boland, B., Maes, F., Scavee, C., and Henrard, S. (2014). Risk scores and geriatric profile: Can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?. Clin. Interv. Aging, 1091.","DOI":"10.2147\/CIA.S62597"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Voigt, K., Gottschall, M., K\u00f6berlein-Neu, J., Sch\u00fcbel, J., Quint, N., and Bergmann, A. (2016). Why do family doctors prescribe potentially inappropriate medication to elderly patients?. BMC Fam. Pract., 17.","DOI":"10.1186\/s12875-016-0482-3"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Jansen, J., McKinn, S., Bonner, C., Irwig, L., Doust, J., Glasziou, P., Bell, K., Naganathan, V., and McCaffery, K. (2017). General Practitioners\u2019 Decision Making about Primary Prevention of Cardiovascular Disease in Older Adults: A Qualitative Study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170228"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Schuling, J., Gebben, H., Veehof, L.J.G., and Haaijer-Ruskamp, F.M. (2012). Deprescribing medication in very elderly patients with multimorbidity: The view of Dutch GPs. A qualitative study. BMC Fam. Pract., 13.","DOI":"10.1186\/1471-2296-13-56"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/01.STR.0000141933.75462.c2","article-title":"Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients","volume":"35","author":"Shireman","year":"2004","journal-title":"Stroke"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e200107","DOI":"10.1001\/jamanetworkopen.2020.0107","article-title":"Outcomes Associated with Oral Anticoagulants Plus Antiplatelets in Patients with Newly Diagnosed Atrial Fibrillation","volume":"3","author":"Fox","year":"2020","journal-title":"JAMA Netw. Open"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/12\/4541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:10Z","timestamp":1760175730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/17\/12\/4541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["ijerph17124541"],"URL":"https:\/\/doi.org\/10.3390\/ijerph17124541","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]}}}